期刊文献+

临床常见不发酵糖革兰阴性杆菌的耐药性探讨 被引量:22

Drug-resistance of Commonly Isolated Gram-negative Nonfermenters
原文传递
导出
摘要 目的探讨临床常见的3种不发酵糖革兰阴性杆菌对抗菌药物的耐药现状,为临床合理用药提供科学依据。方法回顾性调查铜绿假单胞菌(PAE)、鲍氏不动杆菌(ABA)、嗜麦芽寡养单胞菌(SMA)医院感染现状及耐药性。结果 PAE和ABA对碳青酶烯类抗菌药物和头孢哌酮/舒巴坦耐药率较低(17.0%~22.9%);SMA对亚胺培南100.0%耐药,PAE对磺胺甲噁唑/甲氧苄啶、庆大霉素、头孢噻肟、哌拉西林的耐药率均>40.0%;ABA对抗菌药物的耐药率已普遍高于PAE。结论不发酵糖革兰阴性杆菌的耐药性已非常严重,应采取有效的监控措施。 OBJECTIVE To investigate the drug-resistance status of three commonly isolated Gram-negative nonfermenters and offer the scientific evidence for reasonable application of antibiotics.METHODS The nosocomial infections status and drug-resistance of Pseudomonas aeruginosa(PAE),Acinetobacter baumannii(ABA) and Stenotrophomonas maltophilia(SMA) were investigated retrospectively.RESULTS The drug-resistance rates of PAE and ABA were low,17.0-22.9% to carbapenems and cefoperazone/sulbactam.100.0% of SMA were resistant to imipenem.The drug-resistance rate of PAE to trimethoprim/sulfamethoxazole,gentamicin,cefotaxime and piperacillin was all above 40.0%.The drug-resistance rates of ABA were generally higher than those of PAE.CONCLUSIONS The drug-resistance in nonfermenters is very serious.The monitoring measures should be adopted.
作者 孙莉军 郑晖
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第15期2294-2295,共2页 Chinese Journal of Nosocomiology
关键词 不发酵糖革兰阴性杆菌 医院感染 流行病学 耐药性 Gram-negative nonfermenters Nosocomial infection Epidemiology Drug-resistance
  • 相关文献

参考文献8

二级参考文献89

共引文献336

同被引文献116

  • 1朱焱,明德松,谢尊金.全部耐药的短稳杆菌耐药机制的初步研究[J].中华医院感染学杂志,2005,15(10):1181-1182. 被引量:6
  • 2曹文,孙自镛,熊志刚.重症监护治疗病房细菌感染分布及耐药性分析[J].华中医学杂志,2007,31(1):19-21. 被引量:11
  • 3赵松,王小文,陈惠德,李文雄,陈秀凯,郑悦,宋阳.外科ICU黄杆菌科致呼吸机相关性肺炎的危险因素及耐药性分析[J].中华医院感染学杂志,2007,17(4):391-393. 被引量:15
  • 4Aloush V,Navon-Venezia S,Seigman-Igra Y,et al.Multi-drug-resistant Pseudomonas aeruginosa:risk factors and clini-cal impact[J].Antimicrob Agents Chemother,2006,50(1):43-48.
  • 5.消毒技术规范[S].[S].中华人民共和国卫生部,2002,11..
  • 6Clinical and Laboratory Standards Institute.Performancestandards for antimicrobial susceptibility testing[S].M100~S18.CLSI,2008:116-118.
  • 7Lambiase A, Catania MR, Del Pezzo M, et al. Achromobacter xy- losoxidans respiratory tract infection in cystic fibrosis patients [J]. Eur J Clin Microbiol Infect Dis, 2011, 30 (8): 973-980.
  • 8Hansen CR, Pressler T, Nielsen KG, et al. Inflammation in achromobacter xylosoxidans infected cystic fibrosis patients [J]. J Cyst Fibros, 2010, 9 (1): 51-58.
  • 9Raso T, Bianco O, Grosso B, et al. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients [J]. APMIS, 2008, 116 (9): 837-841.
  • 10Bonomo RA, Szabo D. Mechanisms of muitidrug resistance in Acinctobac- ter species and Pseudomonas aeruginosa [ J. C]om Infect Dis, 2006,43 (Suppl 2) :49.

引证文献22

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部